PAN3 and rectum adenocarcinoma: Notably, our combined analysis of the above three databases identified seven cancer types in which PAN3-AS1 expression levels were upregulated, including COAD, cholangiocarcinoma (CHOL), esophageal carcinoma (ESCA), HNSC, liver hepatocellular carcinoma (LIHC), rectum adenocarcinoma (READ), and stomach adenocarcinoma (STAD).